Cephalexin and Vimovo drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cephalexin (cephalexin) and Vimovo (esomeprazole magnesium; naproxen). Common drug interactions include chronic kidney disease among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Cephalexin and Vimovo. It is created by eHealthMe based on reports of 87 people who take the same drugs from the FDA, and is updated regularly.

What is Cephalexin?

Cephalexin has active ingredients of cephalexin. It is often used in infection. eHealthMe is studying from 30,580 Cephalexin users. Check the latest studies of Cephalexin.

What is Vimovo?

Vimovo has active ingredients of esomeprazole magnesium; naproxen. It is often used in osteoarthritis. eHealthMe is studying from 9,608 Vimovo users. Check the latest studies of Vimovo.

On Jul, 08, 2026

87 people who take Cephalexin and Vimovo together, and have interactions are studied.

Cephalexin and Vimovo drug interactions.

What are the common drug interactions of Cephalexin and Vimovo, by gender? *:

female:

Chronic kidney disease
Renal failure (kidney dysfunction)
Renal injury (kidney injury)
Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
Abdominal pain upper
Drug hypersensitivity
Drug ineffective
Drug tolerance decreased
Erythema (redness of the skin)
Hypoaesthesia (reduced sense of touch or sensation)

male:

Chronic kidney disease
Renal failure (kidney dysfunction)
Bone pain
Emotional distress
Mobility decreased (ability to move is reduced)
Nerve compression
Oedema peripheral (superficial swelling)
Osteopenia (a condition where bone mineral density is lower than normal)
Respiratory arrest (cessation of normal respiration due to failure of the lungs to function effectively)
Spinal cord neoplasm (tumour of spinal cord)

What are the common drug interactions of Cephalexin and Vimovo, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Renal failure (kidney dysfunction)

40-49:

Oedema peripheral (superficial swelling)
Renal failure (kidney dysfunction)
Abdominal pain upper
Chronic kidney disease
Drug hypersensitivity
Drug ineffective
Drug tolerance decreased
Erythema (redness of the skin)
Hypoaesthesia (reduced sense of touch or sensation)
Joint swelling

50-59:

Chronic kidney disease
Renal failure (kidney dysfunction)
Renal injury (kidney injury)
Nephrogenic anaemia (anaemia due to kidney disease)
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
Death
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Depression
Respiratory arrest (cessation of normal respiration due to failure of the lungs to function effectively)

60+:

Renal failure (kidney dysfunction)
Chronic kidney disease
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
Drug hypersensitivity
Drug ineffective
Drug tolerance decreased
Dyspepsia (indigestion)
Erythema (redness of the skin)
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Hypoaesthesia (reduced sense of touch or sensation)

What are the existing conditions these people have? *

Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 52 people, 59.77%
High Blood Cholesterol: 23 people, 26.44%
High Blood Pressure: 17 people, 19.54%
Pain: 15 people, 17.24%
Indigestion: 9 people, 10.34%
Depression: 8 people, 9.20%
Gout (uric acid crystals building up in the body): 7 people, 8.05%
Fluid Retention (an abnormal accumulation of fluid in the blood): 7 people, 8.05%
Diabetes: 7 people, 8.05%
Blood Pressure Abnormal: 7 people, 8.05%

* Approximation only. Some reports may have incomplete information.

Do you take Cephalexin and Vimovo?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously